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Highlights (85 characters with spaces) 
 
• Fragmentation of phosphoramidate-containing peptides by CID in a QIT was assessed  
• pHis homodimer formation facilitates intermolecular phosphate transfer during CID 
• Dimer formation and phosphate transfer is dependent on a C-terminal basic Lys 
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Abstract  
The hydrogen bonds and electrostatic interactions that form between the protonated side 
chain of a basic residue and the negatively charged phosphate of a phosphopeptide can play 
crucial roles in governing their dissociation pathways under low-energy collision-induced 
dissociation (CID). Understanding how phosphoramidate (i.e. phosphohistidine, 
phospholysine and phosphoarginine), rather than phosphomonoester-containing peptides 
behave during CID is paramount in investigation of these problematic species by tandem 
mass spectrometry. To this end, a synthetic peptide containing either phosphohistidine (pHis) 
or phospholysine (pLys) was analysed by ESI-MS using a Paul-type ion trap (AmaZon, 
Bruker) and by travelling wave ion mobility-mass spectrometry (Synapt G2-Si, Waters). 
Analysis of the products of low-energy CID demonstrated formation of a doubly 
‘phosphorylated’ product ion arising from intermolecular gas-phase phosphate transfer within 
a phosphopeptide dimer. The results are explained by the formation of a homodimeric 
phosphohistidine (pHis) peptide non-covalent complex (NCX), likely stabilized by the 
electrostatic interaction between the pHis phosphate group and the protonated C-terminal 
lysine residue of the peptide. To the best of our knowledge this is the first report of 
intermolecular gas-phase phosphate transfer from one phosphopeptide to another, leading to a 
doubly phosphorylated peptide product ion.  
 
Keywords: CID; phosphotransfer; phosphoramidate; histidine phosphorylation; gas-phase 
dimer; non-covalent interactions. 
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Graphical abstract  
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Abbreviations  
 
NCX:  non-covalent complex 
pArg:  phosphoarginine  
pHis:  phosphohistidine  
pLys:  phospholysine  
TWIMS:  travelling wave ion mobility-mass spectrometry 
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1. Introduction 
Mass spectrometry has become an extremely powerful analytical tool for the qualitative and 
quantitative analysis of protein phosphorylation, being able to provide data as to the position 
and the extent (or stoichiometry) of the modification.[1-3] Tandem mass spectrometry, 
wherein precursor ions are induced to dissociate using a variety of activation techniques prior 
to analysis of the resultant products, is the key step for localization of the modification site. 
Despite the advantages and availability of electron-driven techniques such as electron transfer 
and electron capture dissociation (ETD and ECD) [4-8], collision-induced dissociation (CID) 
remains the most widely used strategy for phosphorylation site mapping. 
Serine and threonine phosphorylated peptides usually undergo elimination of phosphoric acid 
(H3PO4) or metaphosphoric acid (HPO3) [4] under typical low-energy CID conditions. This 
behavior represents a major challenge, not only to the identification of the phosphorylation 
site, but also for peptide sequence identification; such predominant loss of the phosphate 
group limits the formation of sequence specific b and y ions necessary for confident sequence 
identification and notably for site localization [4]. Under a low proton mobility environment, 
when the ionizing protons are sequestered to the most basic residues of a tryptic peptide 
(arginine and lysine), the elimination of (meta) phosphoric acid is thought to be promoted by 
the occurrence of an intramolecular hydrogen bond between the protonated C-terminal lysine 
or arginine and the oxygens of the phosphate group [9, 10]. This interaction lowers the 
activation energy associated with the proton transfer from the C-terminus to the phosphate 
[10], thus assisting the elimination of H3PO4 via intramolecular nucleophilic substitution  [9, 
10]. In an analogous manner to phosphomonoester-containing peptides, peptides with 
phosphate covalently bound to other amino acids, such as phosphohistidine (pHis), 
phospholysine (pLys) or phosphoarginine (pArg), are also prone to undergo prevalent neutral 
loss during CID [11-14]. Additionally, the mass spectrometric (MS) analysis of such 
phosphopeptides is made even more challenging due to the intrinsic instability of the 
phosphoramidate bond under the acidic conditions typically required for positive ion mode 
mass spectrometry [11, 15], thus adding yet another hurdle to their identification by MS.  
Phosphorylated peptides have been demonstrated to form non-covalent complexes (NCX) 
due to interaction of the phosphorylated residue with a protonated quaternary amine [16-19]. 
The guanidinium group of a protonated arginine (PA= 251.2 kcal/mol) [20], and the ε-
ammonium group of a protonated lysine (PA=239.4 kcal/mol) [20], can engage in strong 
electrostatic interactions with the phosphate of a phosphorylated amino acid residue which 
holds a partial or net negative charge [16]. Lone pairs of electrons on the oxygens of the O-
phosphoester can also drive the formation of hydrogen bonds with the protonated side chains 
of Arg and Lys, thus increasing the overall stability of the complex [9, 19, 21]. An in-depth 
description of the strength of the hydrogen bond interaction between phosphorylated residues 
(Ser and Tyr) and the protonated side chains of Arg and Lys was recently provided by Rapp 
and co-workers [22, 23]. The phosphate-ammonium bond, which plays a major role in 
biological systems [24], is maximized in the gas phase, a medium where electrostatic 
interactions are known to be stronger than in solution, due to the considerably lower 
dielectric constant of the vacuum (ε=1) as compared to solvents like water (ε=80). It is 
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therefore expected that any such electrostatic interactions will play an even bigger role in the 
vacuum, controlling the gas-phase ion chemistry of the species in which it is established.  
Several studies have reported on the strength of the phosphate-guanidinium non-covalent 
bond network [16-19]. In one of the earliest reports, Jackson et al. [17] investigated the 
dissociation patterns of the phosphate-arginine non-covalent bond using a Ser phosphorylated 
peptide and an Arg-rich basic peptide as components of the NCX.  When subjected to CID, 
two major dissociation channels were observed: disruption of the NCX with concomi ant 
separation of the two peptides, and the formation of a new ionic product corresponding to a 
species which was 80 Da larger than the basic peptide. This suggested that CID resulted in 
cleavage between the serine oxygen and the phosphorous atom, releasing HPO3 which was 
still engaged in electrostatic interaction with the guanidinium moiety in the Arg-rich peptide, 
highlighting the remarkable strength of this interaction.   
Evidence of phosphate relocation during phosphopeptide CID, resulting in sequence 
scrambling and the limited formation of non-native phosphorylated peptides have been 
reported in both positive [21, 25-27], and negative [28, 29] ion mode. However, to our 
knowledge there is no evidence to date of intermolecular phosphate transfer to a previously 
phosphorylated peptide ion, resulting in the formation of a doubly ‘phosphorylated’ CID 
product. Unlike Ser, Thr and Tyr which form phosphomonesters with a single phosphate 
group, His can be diphosphorylated on the 1- and 3- positions of the imidazole ring [30].  The 
high hydrolysis energy of the phosphoramidate bond also means that pHis/pLys/pArg 
residues are more likely to participate in phosphate group transfer than pSer/pThr/pTyr, a 
necessity of the function of pHis in two-component signaling systems [31]. Here we 
investigate the behavior of these more reactive pHis/pLys peptides during CID.   
Using the synthetic phosphorylated peptide p(FVIAFILHLVK), containing either pHis or 
pLys, we demonstrate that electrospray ionization (ESI) results in a pHis homodimer which, 
following low-energy CID in a Paul-type ion trap, generates a product ion 80 Da bigger than 
the precursor ion, indicative of phosphate transfer between the two components of the dimer. 
MS3 experiments on the product of the phosphate transfer confirmed its identity as a doubly 
‘phosphorylated’ peptide. Although the exact nature of the bond between the additional 
phosphate moiety and the original singly phosphorylated peptide has not yet been 
ascertained, interaction with the N-terminus can be excluded. That a phosphate moiety can 
remain bound to a positively charged Arg residue upon CID of the corresponding NCX has 
already been reported [14-17]; here we present the first evidence to demonstrate that such 
phosphotransfer can occur to an already phosphorylated peptide ion.  
 
2. Materials and methods 
2.1 Peptide phosphorylation  
Peptide FVIAFILHLVK (98% purity) was synthesized (Genescript) and provided as dry 
powder. Potassium phosphoramidate (KNH2PO3H2; KPA) was synthesized from phosphoryl 
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chloride and ammonia as described previously [32]. Phosphorylation was performed in water 
at pH 8 by adding 25 equivalents of KPA to 1 equivalent of peptide. The reaction was left to 
proceed overnight at room temperature, after which the solution was diluted to a final 
concentration of 1 pmol/µL in CH3CN:H2O 50:50 (v/v) and used for MS analysis. 
2.2 ESI-QIT MS/MS  
Phosphorylated peptide solutions were diluted in CH3CN:H2O 1:1 (v/v) to 1 pmol/µL and 
directly infused into an AmaZon ion trap (Bruker) through an electrospray source, at a flow 
rate of 1 µL/min. Source and octopole ion guide settings were adjusted to minimize in-source 
dissociation. In particular, the desolvating voltage in the ESI source and the acceleration 
voltages in the ion funnel were adjusted to final values of 110 and 80 V (with the standard 
acquisition parameters being 140 and 100 V respectively). Lower values of these two 
potentials resulted in a reduced ion transmission. Full scan ESI-mass spectra were acquired in 
the 150-2000 m/z range. CID product ion mass spectra were obtained using He as the 
collision gas. The MS/MS fragmentation amplitude was set at 1.20 V, and ramped from 30 to 
300% of the set value.   
2.3 Travelling Wave Ion Mobility Mass Spectrometry  
Phosphorylated peptide solutions were diluted in CH3CN:H2O 1:1 (v/v) to 1 pmol/µL and 
directly infused into a Synapt G2-Si HDMS instrument (Waters) through a nanospray source, 
at a flow rate of 0.5 µL/min. The capillary, cone voltage and source temperature were 
typically set to 2.7 kV, 40 V and 80oC respectively. The IM travelling wave speed was set to 
630 m/s and the wave height set at its maximum 40 V. The nitrogen drift gas flow was set at 
90 mL/min for all experiments. Phosphopeptide CID was induced in the transfer cell using 
argon collision gas at collision energy (CE) of 30 V. For analysis of the dimer, the capillary 
voltage was set at 1.95 kV, while the wave speed was reduced to 311 m/s. Mass spectra were 
processed using MassLynx V4.1 and mobilograms using DriftScope v2.1 (both Waters, UK). 
3. Results and discussion 
3.1 Synthesis and characterization of p[FVIAFILHLVK] 
The products of the reaction of the non-phosphorylated synthetic peptide FVIAFILHLVK 
with potassium phosphoramidate (KNH2PO3H2; KPA) was assessed by ESI-MS/MS. The full 
scan ESI mass spectrum of the reaction mixture (Fig. 1) is characterized by the presence of a 
doubly charged ion at m/z 690.5, corresponding to the doubly protonated phosphorylated 
species. Also present is a doubly charged ion at m/z 650.5, matching the doubly charged non-
phosphorylated FVIAFILHLVK, indicating either incomplete phosphorylation or potentially 
dephosphorylation of the product of the synthesis either in solution, or during ESI due to 
acceleration and collision with residual gas in the source region. Due to the relatively high 
level of potassium ions in the reaction solution, ions corresponding to the non-phosphorylated 
and phosphorylated peptide cationized by one proton and one potassium ion are also 
observed (m/z 669.9 and m/z 709.5). Singly charged ions for these species were also 
observed, albeit at ~100-fold lower levels (Fig. 1 inset). Although the relative signal intensity 
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of the non-phosphorylated species are significantly greater than the phosphorylated peptide 
ions, the potential difference in ionization efficiency between phosphorylated and non-
phosphorylated peptides [33, 34] means that no assumptions can be made regarding the 
relative efficiency of the reaction, save to say that it is likely to be incomplete. 
When isolated in the ion trap and induced to dissociate by resonant excitation CID, the ion at 
m/z 690.5 generated a product ion mass spectrum (Fig. 2) indicative of a heterogeneous 
population of [FVIAFILpHLVK + 2H]2+ and [FVIAFILHLVpK + 2H]2+; of the product ions 
still retaining the phosphate group and therefore of utility for unambiguous phosphosite 
localisation, two pHis-specific b-ions (b8 and b10) were observed, as were three y-ions (y1, y2 
and y3) suggesting a phosphorylated C-terminal Lys. KPA treatment is known to 
phosphorylate Lys residues,[35] although treatment of His-containing peptides additionally 
containing Lys has been reported to result preferentially in His modification, with minimal 
modification of Lys [36]. Interestingly, a relatively high intensity ion at m/z 581.8 was also 
observed (Fig. 2) which could only be ascribed to one of two products of a rearranged y-ion; 
[[y102]y9]2+ and [[y103]b9+H2O]2+ [37] are isobaric and cannot therefore be distinguished 
under these conditions. The formation of sequence scrambled products arising from y-ions, 
resulting in peptide sequence rearrangement, has already been reported and appears to be 
reliant on the presence of a basic residue near the peptide C-terminus, suggesting that this 
product is likely to have arisen from the pHis, rather than the pLys, phosphoisomer.[38] 
Separation of the ion at m/z 690.5 by travelling wave ion mobility-mass spectrometry 
(TWIMS) into two species of distinct conformation confirmed synthesis of the two 
phosphoisomers; the observation of pHis specific product ions deriving from the species with 
lower mobility (longer drift time) and pLys specific product ions from the ion with higher 
mobility (faster drift time) (Supp. Fig. 1) precluded the formation of the pLys-containing 
peptide purely as a result of gas-phase interconversion of these phosphoisomers during CID. 
Additionally, the formation of only singly, rather than multiply phosphorylated peptides (Fig. 
1) indicates firstly that under the conditions used no di-phosphorylated His was formed (or at 
least was stable for analysis) and also that modification of the His and Lys residue on this 
peptide are mutually exclusive. 
As expected, the spectrum showed intense neutral loss product ions, including at m/z 641.5 
and 650.5, corresponding respectively to the elimination of HPO3 with or without H2O from 
the precursor ion. 
3.2 Evidence for gas-phase phosphate transfer within the 
[FVIAFILpHLVK+2H+]2+dimer 
The mass spectrum of the phosphorylation reaction product (Fig. 1) also shows a peak 
centered at m/z 1380, corresponding to a singly protonated phosphorylated peptide 
p(FVIAFILHLVK) (Fig. 1 inset). As expected for a phosphorylated peptide under a low 
proton mobility environment [8], CID of this ionic species (Fig. 3) generated a product ion 
spectrum dominated by a base peak at m/z 1281.5, originating from neutral loss of HPO3 
from the precursor ion, with concomitant elimination of H2O, possibly from the C-terminal 
Page 10 of 20
Ac
ce
pte
d M
an
us
cri
pt
10 
 
carboxy group. Minor peaks associated with the elimination of HPO3 (m/z 1299.5), or of H2O 
(m/z 1361.4) from the precursor ions are also present. The only sequence-specific product 
ions are b8Δ (m/z 941.4), b9Δ (m/z 1054.4) and b10Δ (m/z 1153.4), none of which give an 
indication as to the phosphoisoform from which they were derived. However interestingly, a 
significant product ion at m/z 1459.4, 80 Da bigger than the precursor ion, can also be 
observed.  
Based on previously reported findings detailing transfer of a phosphate moiety within a NCX 
comprising a phosphopeptide and an Arg-containing peptide [14-17], we hypothesized that 
the ion at m/z 1459.4 might originate from a similar process: HPO3 dissociates from the 
pHis/pLys residue of one component of a dimer, remaining associated with the other 
phosphopeptide in the dimer. The original dimer [2p(FVIAFILHLVK)+2H+]2+ is isobaric to 
the singly protonated peptide p(FVIAFILHLVK) (m/z 1379.9) and will therefore be co-
isolated prior to CID. Comparison of the experimental isotope distribution with the 
theoretical isotope distribution for a mixed population of the singly protonated monomer 
[M+H]+ and the doubly protonated dimer [M2+2H]2+ (Fig. 4A) certainly indicates that both 
species are present. Moreover, TWIMS analysis shows multiple arrival time distributions 
(ATDs) for these ions indicative of distinct conformations (Fig. 4B). Extraction of the ions 
with the longer ATD (red) yielded a mass spectrum representative of [M+H]+ (Fig. 4C), 
while the ions with the faster ATD (blue) derived from the [M2+2H]2+ species (Fig. 4D). As 
previously observed (Supp. Fig. 1), an important feature of the monomeric ATD (red) is the 
observation of multiple non-resolved conformations (Fig. 4E) corresponding (in part) to 
conformational differences of the pLys and pHis phosphoisomers.   
Observation of a doubly charged product ion at m/z 650.2 in Fig. 3, corresponding to a 
doubly protonated species of the non-phosphorylated peptide FVIAFILHLVK produced via 
HPO3 elimination, further supports the theory of intermolecular phosphate transfer by means 
of dimer formation. If the ionic population centered at m/z 1379.5 were only composed of 
singly charged p(FVIAFILHLVK), the doubly charged species at m/z 650.2 could not 
possibly be generated. Additionally, the possibility that the dimer may be composed of a 
doubly phosphorylated and a non-phosphorylated peptide can be discarded on account of the 
fact that a doubly phosphorylated peptide could not be detected as either a singly protonated 
(m/z 1459.5) or doubly protonated (m/z 730.5) ion upon ESI-MS of the reaction mixture (Fig. 
1). 
To confirm our hypothesis, an MS3 experiment was performed in which the ion centered at 
m/z 1380 (corresponding to the phosphopeptide homodimer [2p(FVIAFILHLVK)+2H+]2+; 
Fig. 1) was subjected to CID, prior to isolation and CID of the resultant product ion at m/z 
1459 (Fig. 5). The main peaks in the MS3 spectrum are associated with the loss of HPO3 + 
H2O (MH+Δ-18) from the precursor (m/z 1361), and elimination of two molecules of HPO3 
(m/z 1299) with concomitant elimination of one (m/z 1281) and two (m/z 1263) molecules of 
H2O. The observation of these elimination pathways, along with the presence of some 
sequence specific diagnostic ions, albeit at a very low signal-to-noise level, confirmed the 
identity of the ionic species at m/z 1459 as that of an intact phosphorylated peptide 
(FVIAFILpHLVK/FVIAFILHLVpK) holding an extra HPO3 moiety.  
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Based on current understanding, it is likely that the additional phosphate group is kept within 
the complex by means of hydrogen bonds and charge-dipole interactions with the C-terminal 
protonated Lys residue (Scheme 1). The peptide under investigation contains a basic C-
terminal Lys and can therefore generate a protonated primary amine. Given the well-
characterized interaction between a phosphate group and a protonated Lys [22], we 
anticipated that a similar non-covalent bond could be established between the phosphate on 
pHis and the ε-ammonium group of the C-terminal Lys, thus mimicking the systems 
previously described [16-19]. If true, this should facilitate the formation of a homodimer via 
electrostatic and hydrogen bond interactions. Additionally, the π-electron density of the 
aromatic imidazole ring of the His and the phenyl ring of the Phe residues could be engaged 
in a π-cation interaction with the protonated side chain of the lysine residue, thus contributing 
to the overall stability of the dimer.   
Phosphate transfer was not observed upon CID of the related peptide FVIAFILpHLV (Supp. 
Fig. 3), generated by proteolytic cleavage of the C-terminal Lys residue by carboxypeptidase-
B (CBP-B), demonstrating that an unmodified C-terminal Lys residue is required for 
stabilization of the homodimeric NCX and subsequent phosphate transfer. We therefore 
envisage a scenario in which a homodimer of the phosphorylated peptide FVIAFILpHLVK 
survives in the gas phase, stabilized by non-covalent interactions between its monomers.  
Based on the isotopic distribution of the ionic population centered at m/z 1380, the system is 
likely composed of a combination of the singly charged pHis/pLys phosphorylated peptides 
[p(FVIAFILHLVK)+H+]+ and the doubly charged homodimer [2(FVIAFILpHLVK)+2H+]2+. 
When activated by CID, the singly charged phosphoramidate-containing peptide ions 
undergo extensive elimination of metaphosphoric acid (with concomitant elimination of 
H2O), to yield the corresponding neutral loss product ions (m/z 1299 and m/z 1281 
respectively), with limited formation of sequence-specific product ions. The pHis 
homodimer, on the other hand, is likely to dissociate to yield its respective monomers, with 
one of them undergoing elimination of HPO3, thus appearing on the spectrum at m/z 1299 
(singly charged) and m/z 650.2 (doubly charged). Release of HPO3 from one of the 
monomers is accompanied by capture of the metaphosphate by the other monomer likely in a 
concerted mechanism [14-17], leading to the doubly phosphorylated species at m/z 1459 
(Scheme 1). Although the exact nature of the interaction between HPO3 and the 
phosphorylated monomer cannot be unambiguously defined based on our data, the strength of 
this bond is such that it can survive the CID process, thereby generating the ionic species at 
m/z 1459. Interestingly, only the dephosphorylated peptide is released upon dissociation of 
the dimer, appearing as a doubly charged ion at m/z 650.2 (Fig. 3), suggesting that the whole 
ionic population corresponding to the phosphorylated peptide is involved in the formation of 
the doubly phosphorylated species. Observation of the y8 and y6-18 ions in the MS3 spectrum 
that retain both phosphate groups, indicates that the second phosphate group is stabilized 
within the C-terminal region of the peptide as would be expected, although the exact site 
cannot be localized. Gas-phase relocation of metaphosphate from phosphorylated Ser, Thr 
and Tyr residues to the C-terminal carboxyl group, and even to amide groups, has been 
reported upon the CID of deprotonated phosphorylated peptides [28, 29].  Transfer of HPO3 
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to the C-terminal carboxy group could be envisaged in this case. However, the observed loss 
of two molecules of HPO3 from b9 and b10 product ions in Fig. 5 points towards His as the 
most likely acceptor residue in the structure of the ions at m/z 1459. 
  
 
Conclusions 
Confirming what has previously been reported for NCXs between phosphorylated peptides 
and Arg-rich sequences, the present work reports for the first time on a homodimeric NCX 
between identical pHis-containing peptides. The driving force for the formation and survival 
of the homodimer in the gas phase is likely provided by electrostatic interaction between the 
phosphates and protonated side chain of the C-terminal Lys residue, with which the 
phosphates also form hydrogen bond interactions. The strength of the non-covalent bonds 
between the pHis and the protonated C-terminal Lys is reflected by the peculiar dissociation 
behavior of the gas-phase dimer, which results in the transfer of a phosphate group from one 
phosphopeptide monomer to the other, leading to the observed doubly phosphorylated 
peptide ion. 
 
Acknowledgements  
 
This work is supported by funding from the Biotechnology and Biological Sciences Research 
Council (BBSRC) [BB/H007113/1 and BB/F00561X/1]. GEH is supported by a BBSRC 
DTP-funded studentship. The authors acknowledge Dr. Stephen Holman for a critical reading 
of this manuscript.
Page 13 of 20
Ac
ce
pte
d M
an
us
cri
pt
13 
 
 
References 
[1] N. Dephoure, K.L. Gould, S.P. Gygi, D.R. Kellogg, Mapping and analysis of phosphorylation sites: a 
quick guide for cell biologists, Mol. Biol. Cell, 24 (2013) 535‐542. 
[2] K. Engholm‐Keller, M.R. Larsen, Technologies and challenges in large‐scale phosphoproteomics, 
Proteomics, 13 (2013) 910‐931. 
[3] M.E. Boehm, J. Seidler, B. Hahn, W.D. Lehmann, Site‐specific degree of phosphorylation in 
proteins measured by liquid chromatography‐electrospray mass spectrometry, Proteomics, 12 
(2012) 2167‐2178. 
[4] P.J. Boersema, S. Mohammed, A.J.R. Heck, Phosphopeptide fragmentation and analysis by mass 
spectrometry, J. Mass Spectrom., 44 (2009) 861‐878. 
[5] R.A. Zubarev, D.M. Horn, E.K. Fridriksson, N.L. Kelleher, N.A. Kruger, M.A. Lewis, B.K. Carpenter, 
F.W. McLafferty, Electron capture dissociation for structural characterization of multiply charged 
protein cations, Anal. Chem., 72 (2000) 563‐573. 
[6] H. Molina, D.M. Horn, N. Tang, S. Mathivanan, A. Pandey, Global proteomic profiling of 
phosphopeptides using electron transfer dissociation tandem mass spectrometry, Proc. Natl. Acad. 
Sci. U. S. A., 104 (2007) 2199‐2204. 
[7] C.K. Frese, H.J. Zhou, T. Taus, A.F.M. Altelaar, K. Mechter, A.J.R. Heck, S. Mohammed, 
Unambiguous Phosphosite Localization using Electron‐Transfer/Higher‐Energy Collision Dissociation 
(EThcD), J. Proteome Res., 12 (2013) 1520‐1525. 
[8] S.M.M. Sweet, H.J. Cooper, Electron capture dissociation in the analysis of protein 
phosphorylation, Expert Review of Proteomics, 4 (2007) 149‐159. 
[9] M. Rozman, Modelling of the gas‐phase phosphate group loss and rearrangement in 
phosphorylated peptides, J. Mass Spectrom., 46 (2011) 949‐955. 
[10] A.M. Palumbo, J.J. Tepe, G.E. Reid, Mechanistic insights into the multistage gas‐phase 
fragmentation behavior of phosphoserine‐ and phosphothreonine‐containing peptides, J. Proteome 
Res., 7 (2008) 771‐779. 
[11] M.B. Gonzalez‐Sanchez, F. Lanucara, M. Helm, C.E. Eyers, Attempting to rewrite History: 
challenges with the analysis of histidine‐phosphorylated peptides, Biochem. Soc. Trans., 41 (2013) 
1089‐1095. 
[12] A.J. Kleinnijenhuis, F. Kjeldsen, B. Kallipolitis, K.F. Haselmann, O.N. Jensen, Analysis of histidine 
phosphorylation using tandem MS and ion‐electron reactions, Anal. Chem., 79 (2007) 7450‐7456. 
[13] K.F. Medzihradszky, N.J. Phillipps, L. Senderowicz, P. Wang, C.W. Turck, Synthesis and 
characterization of histidine‐phosphorylated peptides, Protein Sci., 6 (1997) 1405‐1411. 
[14] S. Napper, J. Kindrachuk, D.J. Olson, S.J. Ambrose, C. Dereniwsky, A.R. Ross, Selective extraction 
and characterization of a histidine‐phosphorylated peptide using immobilized copper(II) ion affinity 
chromatography and matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry, 
Anal. Chem., 75 (2003) 1741‐1747. 
[15] J.M. Kee, T.W. Muir, Chasing phosphohistidine, an elusive sibling in the phosphoamino acid 
family, ACS Chem. Biol., 7 (2012) 44‐51. 
[16] S.N. Jackson, S.C. Moyer, A.S. Woods, The role of phosphorylated residues in peptide‐peptide 
noncovalent complexes formation, J. Am. Soc. Mass Spectrom., 19 (2008) 1535‐1541. 
[17] S.N. Jackson, H.Y. Wang, A.S. Woods, Study of the fragmentation patterns of the phosphate‐
arginine noncovalent bond, J. Proteome Res., 4 (2005) 2360‐2363. 
[18] S.N. Jackson, H.Y. Wang, A. Yergey, A.S. Woods, Phosphate stabilization of intermolecular 
interactions, J. Proteome Res., 5 (2006) 122‐126. 
[19] A.S. Woods, S.C. Moyer, S.N. Jackson, Amazing stability of phosphate‐quaternary amine 
interactions, J. Proteome Res., 7 (2008) 3423‐3427. 
Page 14 of 20
Ac
ce
pte
d M
an
us
cri
pt
14 
 
[20] E.P.L. Hunter, S.G. Lias, Evaluated gas phase basicities and proton affinities of molecules: An 
update, J. Phys. Chem. Ref. Data, 27 (1998) 413‐656. 
[21] A.M. Palumbo, G.E. Reid, Evaluation of gas‐phase rearrangement and competing fragmentation 
reactions on protein phosphorylation site assignment using collision induced dissociation‐MS/MS 
and MS3, Anal. Chem., 80 (2008) 9735‐9747. 
[22] C. Rapp, H. Klerman, E. Levine, C.L. McClendon, Hydrogen bond strengths in phosphorylated and 
sulfated amino acid residues, PLoS One, 8 (2013) e57804. 
[23] D.J. Mandell, I. Chorny, E.S. Groban, S.E. Wong, E. Levine, C.S. Rapp, M.P. Jacobson, Strengths of 
hydrogen bonds involving phosphorylated amino acid side chains, J. Am. Chem. Soc., 129 (2007) 820‐
827. 
[24] K.A. Schug, W. Lindner, Noncovalent binding between guanidinium and anionic groups: focus on 
biological‐ and synthetic‐based arginine/guanidinium interactions with phosph[on]ate and 
sulf[on]ate residues, Chem Rev, 105 (2005) 67‐114. 
[25] N. Mischerikow, A.F. Altelaar, J.D. Navarro, S. Mohammed, A.J. Heck, Comparative assessment 
of site assignments in CID and electron transfer dissociation spectra of phosphopeptides discloses 
limited relocation of phosphate groups, Mol. Cell. Proteomics, 9 (2010) 2140‐2148. 
[26] L. Cui, I. Yapici, B. Borhan, G.E. Reid, Quantification of competing H3PO4 versus HPO3 + H2O 
neutral losses from regioselective 18O‐labeled phosphopeptides, J. Am. Soc. Mass Spectrom., 25 
(2014) 141‐148. 
[27] L. Cui, G.E. Reid, Examining factors that influence erroneous phosphorylation site localization via 
competing fragmentation and rearrangement reactions during ion trap CID‐MS/MS and ‐MS(3.), 
Proteomics, 13 (2013) 964‐973. 
[28] M. Edelson‐Averbukh, A. Shevchenko, R. Pipkorn, W.D. Lehmann, Gas‐phase intramolecular 
phosphate shift in phosphotyrosine‐containing peptide monoanions, Anal. Chem., 81 (2009) 4369‐
4381. 
[29] T.T. Tran, T. Wang, S. Hack, P. Hoffmann, J.H. Bowie, Can collision‐induced negative‐ion 
fragmentations of [M‐H](‐) anions be used to identify phosphorylation sites in peptides?, Rapid 
Commun. Mass Spectrom., 25 (2011) 3537‐3548. 
[30] D.E. Hultquist, R.W. Moyer, P.D. Boyer, The preparation and characterization of 1‐
phosphohistidine and 3‐phosphohistidine, Biochemistry, 5 (1966) 322‐331. 
[31] P.V. Attwood, M.J. Piggott, X.L. Zu, P.G. Besant, Focus on phosphohistidine, Amino Acids, 32 
(2007) 145‐156. 
[32] Y.F. Wei, H.R. Matthews, Identification of phosphohistidine in proteins and purification of 
protein‐histidine kinases, Methods Enzymol., 200 (1991) 388‐414. 
[33] M. Marcantonio, M. Trost, M. Courcelles, M. Desjardins, P. Thibault, Combined enzymatic and 
data mining approaches for comprehensive phosphoproteome analyses: application to cell signaling 
events of interferon‐gamma‐stimulated macrophages, Mol. Cell. Proteomics, 7 (2008) 645‐660. 
[34] Y. Ishihama, F.Y. Wei, K. Aoshima, T. Sato, J. Kuromitsu, Y. Oda, Enhancement of the efficiency of 
phosphoproteomic identification by removing phosphates after phosphopeptide enrichment, J. 
Proteome Res., 6 (2007) 1139‐1144. 
[35] K. Kowalewska, P. Stefanowicz, T. Ruman, T. Fraczyk, W. Rode, Z. Szewczuk, Electron capture 
dissociation mass spectrometric analysis of lysine‐phosphorylated peptides, Bioscience reports, 30 
(2010) 433‐443. 
[36] U.M. Hohenester, K. Ludwig, S. Konig, Chemical phosphorylation of histidine residues in proteins 
using potassium phosphoramidate ‐‐ a tool for the analysis of acid‐labile phosphorylation, Current 
drug delivery, 10 (2013) 58‐63. 
[37] R. Chawner, S.J. Gaskell, C.E. Eyers, Proposal for a common nomenclature for peptide fragment 
ions generated following sequence scrambling during collision‐induced dissociation, Rapid Commun. 
Mass Spectrom., 26 (2012) 205‐206. 
[38] M. Miladi, B. Harper, T. Solouki, Evidence for sequence scrambling in collision‐induced 
dissociation of y‐type fragment ions, J. Am. Soc. Mass Spectrom., 24 (2013) 1755‐1766. 
Page 15 of 20
Ac
ce
pte
d M
an
us
cri
pt
15 
 
 
Figure 1. ESI-ion trap full scan mass spectrum of the products of the reaction between 
peptide FVIAFILHLVK and potassium phosphoramidate (KNH2PO3H2). Inset shows an 
enhanced region of the mass spectrum encompassing m/z range 1280 – 1400. 
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Figure 2. CID product ion mass spectrum of the doubly charged ion of the phosphorylated 
peptide p[FVIAFILHLVK + 2H]2+ at m/z 690.5, indicating a heterogeneous population of 
[FVIAFILpHLVK + 2H]2+ and [FVIAFILHLVpK + 2H]2+, whose specific y-ions are labeled 
in italics (grey). Δ indicates loss of 80 Da (HPO3); * indicates observation of both 
phosphorylated and non-phosphorylated product ions. 
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Figure 3. CID product ion mass spectrum of the singly charged ion of the phosphorylated 
peptide [p(FVIAFILHLVK) + H]+ at m/z 1379.5. Δ indicates loss of 80 Da (HPO3). 
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Figure 4. Travelling wave ion mobility-mass spectrometry analysis of the ions at m/z 1379.5 
demonstrating a mixed population of singly protonated phosphopeptide monomer [M+H]+ 
and doubly protonated dimer [M2+2H]2+. (A) Isotopic distribution and (B) arrival time 
distribution (ATD) of the mixed population. Inset (A)  depicts the theoretical isotope 
distribution (assuming 1:1 stoichiometry) of the [M+H]+ and [M2+2H]2+. Extracted ion 
current for the (C) longer (red) and (D) shorter (blue) ATDs (E) indicating mobility 
separation of the monomeric and dimeric populations. 
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Figure 5. MS3 CID product ion mass spectrum of ions at m/z 1459.4 generated by CID of 
ions at m/z 1379.5. The doubly ‘phosphorylated’ peptide is represented by 
p(FVIAFILpHLVK). Δ indicates loss of 80 Da (HPO3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 20 of 20
Ac
ce
pte
d M
an
us
cri
pt
20 
 
 
 
 
Scheme 1. Proposed mechanism for the formation of the ions at m/z 1459.8. The scheme depicts a 
homodimer of the phosphopeptide FVIAFILpHLVK (m/z 1379.8), whose components can undergo 
elimination of metaphosphoric acid HPO3 and generation of a transient ternary complex, which then 
evolves to give the dephosphorylated peptide at m/z 1299.8 and the ‘doubly’ phosphorylated peptide 
at m/z 1459.8. 
 
 
 
 
 
